Hyundai Pharmaceutical Co., Ltd. (KRX: 004310)

Hyundai Pharmaceutical Revenue

In the fiscal year ending November 30, 2013, Hyundai Pharmaceutical had annual revenue of 108.14B KRW with 5.75% growth. Hyundai Pharmaceutical had revenue of 25.51B in the quarter ending November 30, 2013, with 5.01% growth.

• Revenue: 108.14B
• Revenue Growth: +5.75%
• P/S Ratio: 0.76
• Revenue / Employee: 275.15M
• Employees: 393
• Market Cap: 97.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2013	108.14B	5.88B	5.75%
Nov 30, 2012	102.25B	-12.02B	-10.52%
Nov 30, 2011	114.28B	2.42B	2.16%
Nov 30, 2010	111.86B	-11.02B	-8.97%
Nov 30, 2009	122.88B	2.36B	1.96%